Use of CSF biomarkers in Alzheimer’s disease clinical trials

被引：0
|
作者：
K. Blennow
H. Zetterberg
机构：
[1] the Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Laboratory
[2] The Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Lab
[3] Sahlgrenska University Hospital,undefined
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
Mild Cognitive Impairment; Lewy Body Dementia; BACE1 Inhibitor; Secretase Inhibitor; Mild Cognitive Impairment Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
    Blennow, Kaj
    Hampel, Harald
    Zetterberg, Henrik
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (01) : 189 - 201
  • [42] CSF biomarkers of Alzheimer disease "Noncognitive" outcomes
    Roe, Catherine M.
    Fagan, Anne M.
    Grant, Elizabeth A.
    Holtzman, David M.
    Morris, John C.
    NEUROLOGY, 2013, 81 (23) : 2028 - 2031
  • [43] The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey
    Caprioglio, Camilla
    Garibotto, Valentina
    Jessen, Frank
    Froelich, Lutz
    Allali, Gilles
    Assal, Frederic
    Frisoni, Giovanni B.
    Altomare, Daniele
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (02) : 535 - 551
  • [44] Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?
    Vyhnalek, Martin
    Laczo, Martina
    Laczo, Jan
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (04) : 1133 - 1136
  • [45] Clinical significance of fluid biomarkers in Alzheimer's Disease
    Lewczuk, Piotr
    Lukaszewicz-Zajac, Marta
    Mroczko, Piotr
    Kornhuber, Johannes
    PHARMACOLOGICAL REPORTS, 2020, 72 (03) : 528 - 542
  • [46] Amyloid biomarkers in Alzheimer's disease
    Blennow, Kai
    Mattsson, Niklas
    Scholl, Michael
    Hansson, Oskar
    Zetterberg, Henrik
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (05) : 297 - 309
  • [47] The use of biomarkers in Alzheimer's disease: a case report
    Stanley, Karen
    Stevens, Tim
    Walker, Zuzana
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2019, 23 (03) : 10 - 14
  • [48] Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
    Hertze, Joakim
    Minthon, Lennart
    Zetterberg, Henrik
    Vanmechelen, Eugeen
    Blennow, Kaj
    Hansson, Oskar
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1119 - 1128
  • [49] MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer's Disease
    Denk, Johannes
    Boelmans, Kai
    Siegismund, Christine
    Lassner, Dirk
    Arlt, Soenke
    Jahn, Holger
    PLOS ONE, 2015, 10 (05):
  • [50] Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
    Fagan, Anne M.
    Xiong, Chengjie
    Jasielec, Mateusz S.
    Bateman, Randall J.
    Goate, Alison M.
    Benzinger, Tammie L. S.
    Ghetti, Bernardino
    Martins, Ralph N.
    Masters, Colin L.
    Mayeux, Richard
    Ringman, John M.
    Rossor, Martin N.
    Salloway, Stephen
    Schofield, Peter R.
    Sperling, Reisa A.
    Marcus, Daniel
    Cairns, Nigel J.
    Buckles, Virginia D.
    Ladenson, Jack H.
    Morris, John C.
    Holtzman, David M.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (226)
12345